Browse All

Current Filters

CLEAR FILTER x

TITLE

Efgartigimod Demonstrates Consistent Improvements in Generalized Myasthenia Gravis Patients of Shorter Disease Duration

Author:Bril, Vera   Vu, Tuan   Brauer, Edward   Kerstens, René   Howard, James   ADAPT Investigator Study Group, in collaboration with the   

Session Name:P1: Autoimmune Neurology: Myasthenia Gravis  

Topic:Autoimmune Neurology  

Program Number:P1.015  

Author Institution:Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, Toronto, ON, Canada  University of South Florida, Morsani College of Medicine, Tampa, FL  argenx, Ghent, Belgium  The University of North Carolina, Chapel Hill, NC  N/A, Yardley, PA  

Dose Selection and Clinical Development of Efgartigimod PH20 Subcutaneous in Patients with Generalized Myasthenia Gravis

Author:Li, George   Li, Yuebing   Vu, Tuan   Korobko, Denis   Smilowski, Marek   Liu, Li   Steeland, Sophie   Van Hoorick, Benjamin   Podhorna, Jana   Casey, Jenna   Noukens, Jan   Van Bragt, Tonke   Utsugisawa, Kimiaki   Wiendl, Heinz   De Bleecker, Jan   Mantegazza, Renato   Howard, James   ADAPT-SC Investigator Study Group, in collaboration with the   

Session Name:P1: Autoimmune Neurology: Myasthenia Gravis  

Topic:Autoimmune Neurology  

Program Number:P1.017  

Author Institution:Medsol Clinical Research Center Inc, Port Charlotte, FL  Cleveland Clinic, Cleveland, OH  University of South Florida, Morsani College of Medicine, Tampa, FL  State Budgetary Healthcare Institution of Novosibirsk Region "State Novosibirsk Regional Clinical Hospital", Novosibirsk, Russian Federation  Medical University of Silesia, Katowice, Poland  argenx, Ghent, Belgium  argenx, Afton, MN  Curare Consulting BV, Etten-Leur, Netherlands  Hanamaki General Hospital, Hanamaki, Japan  University of Münster, Münster, Germany  Ghent University Hospital, Ghent, Belgium  Fondazione Istituto Neurologico Carlo Besta, Milan, Italy  The University of North Carolina, Chapel Hill, NC  N/A, Yardley, PA